Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy

Blood

Volumn 87, Issue 3, 1996, Pages 912-918

  Baldini, L ^a   Guffanti, A ^b   Cesana, B M ^b   Colombi, M ^b   Chiorboli, O ^b   Damilano, I ^b   Maiolo, A T ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BENCE JONES PROTEIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGED; ARTICLE; BONE MARROW CELL; CLINICAL FEATURE; DISEASE COURSE; FEMALE; FOLLOW UP; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; LABORATORY TEST; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MONOCLONAL IMMUNOGLOBULINEMIA; MULTIPLE MYELOMA; PLASMA CELL; PRIORITY JOURNAL; PROTEINURIA; SURVIVAL; WALDENSTROEM MACROGLOBULINEMIA;

EID: 0030022589     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.3.912.bloodjournal873912     Document Type: Article

References (23)

1. Kyle RA: Benign monoclonal gammopathy: A misnomer? JAMA 251:1849, 1984
2. Durie BGM: Staging and kinetics of multiple myeloma. Semin Oncol 13:300, 1986
3. Kyle RA, Lust JA: Monoclonal gammopathies of undetermined significance. Semin Hematol 26:176, 1989
4. Lichtman MA: Essential and secondary monoclonal gammopathies in Williams WJ, Beutler E, Erslev AJ, Lichtman MA (eds): Hematology. New York, NY, McGraw-Hill, 1990, p 1109
5. Greipp RP: Advances in the diagnosis and management of myeloma. Semin Hematol 29:24, 1992 (suppl 2)
6. Baldini L, Nobile-Orazio E, Guffanti A, Barbieri S, Carpo M, Cro L, Cesana B, Damilano I, Maiolo ATM: Peripheral neuropathy in IgM monoclonal gammopathy and Waldenstrom's macroglobulinemia: A frequent complication in elderly males with low MAG-reactive serum monoclonal component. Am J Hematol 45:25, 1994
7. Berkson J, Gage RP: Calculation of survival rates for cancer. Proc Staff Meet Mayo Clin 25:270, 1950
8. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemoter Rep 50:163, 1966
9. Cox DR: Regression models and life tables (with discussion). J Royal Stat Soc 34:187, 1972
10. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
11. Kyle RA, Greipp PR: Monoclonal gammopathies of undetermined origin, in Wiernick PH, Canellos GP, Kyle RA (eds): Neoplastic Diseases of the Blood, vol 2. New York, NY, Churchill Livingstone, 1985, p 653
12. Kyle RA: "Benign" monoclonal gammopathy - After 20 to 35 years of follow-up. Mayo Clin Proc 68:26, 1993
13. Blade J, Lopez-Guillermo A, Rozman C, Cervantes F, Salgado C, Aguilar JL, Vives-Corrons J-L, Montserrat E: Malignant transformation and life expectancy in monoclonal gammopathy of undetermined significance. Brit J Haematol 81:391, 1992
14. Bergsagel DE: Plasma cell myeloma, in Williams WJ, Beutler E, Erslev AJ, Lichtman MA (eds): Hematology. New York, NY, McGraw-Hill, 1990, p 1114
15. Ucci G, Riccardi A, Luoni R, Ascan E: Presenting features of monoclonal gammopathies: An analysis of 684 newly diagnosed cases. J Intern Med 234:165, 1993
16. Møller-Petersen J, Schmidt EB: Diagnostic value of the concentration of M-component in initial classification of monoclonal gammopathy. Scand J Haematol 36:295, 1986
17. Carter A, Tatarsky I: The physiopathological significance of benign monoclonal gammopathy: A study of 64 cases. Br J Haematol 46:565, 1980
18. Peltonen S, Wassatjerna C, Wager O: Clinical features of patients with a serum M component. Acta Med Scand 203:257, 1978
19. Pruzanski W, Gidon MS, Roy A: Suppression of polyclonal immunoglobulins in multiple myeloma: Relationship to the staging and other manifestations at diagnosis. Clin Immunol Immunopathol 17:280, 1980
20. Hobbs JR: Paraproteins, benign or malignant? Br Med J 3:699, 1967
21. Seligmann M, Basch A: The clinical significance of pathological immunoglobulins, in Plenary Session Papers of the XII International Congress of Hematology. New York, NY, International Society of Hematology, 1968, p 21
22. Dammacco F, Waldenström J: Bence Jones proteinuria in benign monoclonal gammopathies: Incidence and characteristics. Acta Med Scand 184:403, 1968
23. Lindstrom FD, Dahlstrom U: Multiple myeloma or benign monoclonal gammopathy? A study of differential diagnostic criteria in 44 cases. Clin Immunol Immunopathol 10:168, 1978